40 results on '"Morra Enrica"'
Search Results
2. Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia
Catalog
Books, media, physical & digital resources
3. Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia.
4. Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia.
5. Prognostic relevance of the flow cytometric count of medullar blasts in myelodysplastic syndromes.
6. Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma.
7. Old and new prognostic factors in acute myeloid leukemia with deranged core-binding factor beta.
8. Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop.
9. Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia.
10. Mutations of CD79A, CD79B and EZH2 genes in immunodeficiency-related non-Hodgkin lymphomas.
11. Dasatinib, even at low doses, is an effective second-line therapy for chronic myeloid leukemia patients resistant or intolerant to imatinib. Results from a real life-based Italian multicenter retrospective study on 114 patients.
12. Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma.
13. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.
14. DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients.
15. Limited Feasibility of Double Transplant in Multiple Myeloma.
16. Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease.
17. Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymphoproliferative disorders.
18. Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders.
19. research paper Incidence of novel N-glycosylation sites in the B-cell receptor of lymphomas associated with immunodeficiency.
20. Short Report Frequent aberrant promoter hypermethylation of O6-methylguanine-DNA methyltransferase and death-associated protein kinase genes in immunodeficiency-related lymphomas.
21. Epstein–Barr virus (EBV) load and interleukin-10 in EBV-positive and EBV-negative post-transplant lymphoproliferative disorders.
22. E2A–PBX1 fusion in adult acute lymphoblastic leukaemia: biological and clinical features.
23. Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia.
24. Invasive aspergillosis in haematological malignancies: Clinical findings and management for intensive chemotherapy completion.
25. Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes.
26. Fludarabine, cytarabine, and granulocyte-colony stimulating factor for the treatment of high risk myelodysplastic syndromes.
27. Hepato-splenic γδ T-cell lymphoma: A rare entity mimicking the hemophagocytic syndrome.
28. Interferon alpha-2b as therapy for patients with Ph'-positive chronic myelogenous leukemia.
29. Bone marrow and blood involvement by non-Hodgkin's lymphoma: A study of clinicopathologic correlations and prognostic significance in relationship to the Working Formulation.
30. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-hodgkin's lymphoma.
31. The role of systemic high-dose cytarabine in the treatment of central nervous system leukemia. Clinical results in 46 patients.
32. Anaplastic large cell (CD30/Ki-1.
33. Hematologic and clinical features of patients with chromosome 5 monosomy or deletion (5q).
34. RESIDUAL MEDIASTINAL WIDENING FOLLOWING THERAPY IN HODGKIN'S DISEASE.
35. Post-remission intensive treatment after induction chemotherapy is feasible in selected elderly patients with acute myeloid leukemia and age ≥75 years: A retrospective analysis of the Rete Ematologica Lombarda.
36. Cyclosporine therapy in refractory/relapsed patients with thrombotic thrombocytopenic purpura.
37. Effective treatment of autoimmune hemolytic anemia and hairy cell leukemia with interferon-α.
38. Multiple myeloma associated to HIV infection: report of two patients.
39. Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network.
40. Nilotinib induced bone marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-chronic myeloid leukemia.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.